Taxotere Hair Loss Lawsuit Information Page Informs Of Potential Chemo Drug Side Effects

Taxotere Hair Loss Lawsuit State Risk Of Permanent Hair Loss From Chemotherapy Drug Beleived To Cause Alopecia In Breast Cancer Patients

Southern Med Law has launched a Taxotere hair loss lawsuit page to provide information on the growing riske of permanent hair loss after receiving the chemotherapy drug for breast cancer. Southern Med Law has spoken with numerous women across the country who have experienced permanent hair loss after chemotherapy when the Taxotere drug was used. Taxotere is at the center of hundreds of lawsuits filed against its developer, Sanofi-Aventis and its subsidiaries. The hair loss lawsuits claim the breast cancer treatment drug causes women to suffer disfigurement, severe and debilitation emotional distress and other injuries because of permanent hair loss, also known as alopecia.

The attorneys at Southern Med Law are investigating Taxotere hair loss lawsuit claims from women who want to know about the legal options available to them.

“Women who say they have been disfigured by Taxotere’s devastating alopecia side-effects are seeking justice for their injuries,” says Dr. François Blaudeau, founder of Southern Med Law.

If you have been prescribed the Taxotere chemotherapy drug to treat breast cancer and have suffered permanent hair loss and other side effects, you can arrange for a free, no-obligation legal evaluation by calling Southern Med Law today at 205-547-5525 or visit www.southernmedlaw.com for more information and news on upcoming meetings and filings.

Taxotere (docetaxel) was approved by the U.S. Food and Drug Administration (FDA) in 1996 to treat women with locally advanced or metastatic breast cancer after previous chemotherapy treatments had failed. Taxotere along with the chemotherapy drugs, doxorubicin and cyclophosphamide, is also used for the adjuvant treatment of patients with operable node-positive breast cancer. Taxotere is part of a family of drugs known as Taxanes which block cell growth by interfering with cell division. Several long-term adverse reactions have been reported in patients taking Taxotere that include:

• Anemia
• Fluid retention
• Gastrointestinal bleeding
• Infections
• Nail disorders
• Nausea and vomiting
• Skin reactions

A clinical study called GEICAM 9805 showed alopecia persisted in the follow-up period of patients for 10 years and 5 months and was observed to be ongoing in 49 patients (9.2 percent) taking Taxotere. Additionally, Alopecia started or worsened during the follow-up period in 42 patients (7.9 percent) taking Taxotere.
[https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020449s059lbl.pdf]
[ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000073/WC500035264.pdf]

Since its approval of Taxotere, the FDA has sent two warning letters over advertisements for the drug. In a letter sent in November 2003, the FDA said Taxotere’s advertisements were false or misleading because they made unsubstantiated effectiveness claims. The federal agency said in an April 2009 letter that the drug’s promotional materials “misleadingly” suggested Taxotere was superior to Taxol (paclitaxel), a competitor drug that is also used to treat breast cancer.

Southern Med Law’s Taxotere Hair Loss Lawsuit page will also include information on a multidistrict litigation established in October 2016 in the U.S. District Court, Eastern District of Louisiana. The federal Taxotere lawsuits filed on behalf of women allege their permanent hair loss has prevented them from working which has resulted in a loss of income, mental anguish, loss and impairment of the quality and enjoyment of life and other injuries. The lawsuits further allege Sanofi-Aventis misled women to believe that Taxotere was safe to use and failed warn doctors and their patients of the chemo drug side effects. (Taxotere Hair Loss Lawsuit Case No. In Re: Taxotere (Docetaxel) Products Liability Litigation – MDL 2740)

About Southern Med Law And Filing A Taxotere Hair Loss Lawsuit

Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in Taxotere Hair Loss Lawsuits. They are not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success. To speak to one of the firm’s Taxotere Hair Loss lawsuit attorneys for a FREE Taxotere Hair Loss Lawsuit consultation please call 205-547-5525 or fill out the online form.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@sml-legal.i-mlaw.com
www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam